Front Range Biosciences Raises $8.5M in Insider Round
September 25, 2019
Great news! Front Range Biosciences raised $8.5M in an Insider Round, which enables us to continue to define the industry and maintain our lead as a technology provider for the breeding and production of new plant varieties and seeds in the hemp, coffee and regulated cannabis industries. The Insider Round increases FRB’s pace of expansion for its Clean Stock® program, breeding program and intellectual property portfolio. Additionally, with our partnerships at renowned research facilities, such as CRAG and UC Davis, this funding will allow us to expand our breeding program’s focus on developing plants with unique traits.
Front Range Biosciences’ CEO and Co-Founder, Dr. Jonathan Vaught, said, “The continued global advancement of cannabis legalization is creating an opportunity for unprecedented growth and innovation in agriculture. The introduction of cannabis to the agricultural market as a new crop with medical, nutritional and industrial applications presents a unique opportunity for us to use modern biotechnology to provide sustainable solutions for farmers around the world.”
Front Range Biosciences advice does not constitute any warranty for a specific outcome, nor does it allow any cause of action against Front Range Biosciences if crop failure occurs. All advice and sales are subject to the Terms and Conditions which can be found at www.frontrangebio.com/termsandconditions.